We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock
MDVL

Delisted

MDVL was delisted on the 12th of February, 2024.

Back to rankings

26 hedge funds and large institutions have $16.5M invested in MedAvail Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 26 → 26 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

15% less capital invested

Capital invested by funds: $19.5M → $16.5M (-$3M)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
5
Closed
2
Calls
$38.2M
Puts
–
Net Calls
+$38.2M
Net Calls Change
+$37.3M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$20.3K
2
Wells Fargo
Wells Fargo
California
+$5.11K
3
TRCT
Tower Research Capital (TRC)
New York
+$4.43K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$230

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$82.7K
2
PVI
Pura Vida Investments
New York
-$69.9K
3
Millennium Management
Millennium Management
New York
-$35.7K
4
BlackRock
BlackRock
New York
-$17.4K
5
CCM
Condor Capital Management
New Jersey
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
RG
1
Redmile Group
California
$8.48M – – –
AWGLSCP
2
ABG-WTT Global Life Science Capital Partners
Hong Kong
$3.68M – – –
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$1.47M -$82.7K -6,481 -5%
ABG
4
Ally Bridge Group
New York
$1.44M – – –
CI
5
Cigna Investments
Connecticut
$586K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$259K – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$245K – – –
DM
8
Deerfield Management
New York
$205K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$45.1K – – –
BlackRock
10
BlackRock
New York
$25K -$17.4K -1,362 -40%
Renaissance Technologies
11
Renaissance Technologies
New York
$19K +$20.3K +1,590 New
PVI
12
Pura Vida Investments
New York
$18.8K -$69.9K -5,474 -83%
Northern Trust
13
Northern Trust
Illinois
$10.5K – – –
State Street
14
State Street
Massachusetts
$10.1K -$536 -42 -5%
TRCT
15
Tower Research Capital (TRC)
New York
$8.41K +$4.43K +347 +102%
Wells Fargo
16
Wells Fargo
California
$5.27K +$5.11K +400 +1,333%
JIC
17
Joel Isaacson & Co
New York
$4.59K – – –
Millennium Management
18
Millennium Management
New York
$3.86K -$35.7K -2,796 -90%
BP
19
BBR Partners
New York
$3.73K – – –
US Bancorp
20
US Bancorp
Minnesota
$3.23K – – –
Charles Schwab
21
Charles Schwab
California
$2.91K – – –
Fidelity Investments
22
Fidelity Investments
Massachusetts
$1.5K – – –
Morgan Stanley
23
Morgan Stanley
New York
$1.21K – – –
NA
24
NewEdge Advisors
Louisiana
$736 – – –
GRP
25
Global Retirement Partners
California
$105 – – –
1
2

MDVL Hedge Fund Activity: Q2 2023 in Review

26 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2023, worth a combined $16.5M — down 15% from $19.5M a quarter earlier.

Fund positioning in MDVL was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $20.3K. The largest seller was Alyeska Investment Group, cutting an estimated $82.7K.

  • 26 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $16.5M of MedAvail Holdings, Inc. Common Stock stock for Q2 2023, down 15% quarter-over-quarter.
  • 2 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2023 and 2 closed out, a net change of 0 holders.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2023 was Renaissance Technologies, an estimated $20.3K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2023 was Alyeska Investment Group, an estimated $82.7K sold.

Based on aggregated 13F filings for Q2 2023.